Cardisan 2.5 mg chewable tablets for dogs
Cardisan 2.5 mg chewable tablets for dogs
Authorised
- Pimobendan
Product identification
Medicine name:
Cardisan 2.5 mg chewable tablets for dogs
Cardisan Vet 2,5 mg purutabletti
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan2.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
All relevant tissuesno withdrawal periodNot applicable
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Package description:
- Cardbox containing 12 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
- Cardbox containing 10 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
- Cardbox containing 9 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
- Cardbox containing 6 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
- Cardbox containing 3 Aluminium-OPA/Aluminium/PVC blisters containing 10 tablets each.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
- Lelypharma B.V.
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 40089
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0380/002
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 6/11/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 27/01/2025